Insight & Updates

Insights & Updates

Insights, Research & Industry Updates

Cyclotek Expands Radiopharmaceutical Manufacturing Capacity in Auckland

Connecting the Dots: Collaboration and Innovation at EANM’24

Think Pink and Cyclotek – Trip to The Living Centre

First Tumorad Dose Administered in World First Clinical Trial

Cyclotek’s contribution to clinical trials in Australia and New Zealand

Cyclotek validates to cGMP 18F FP-CIT (PET DAT Scan) for use in Parkinson Disease

PSMA PET scans for prostate cancer will be funded through the Medical Benefits Schedule (MBS)

Advanced manufacturing in Australia: Applied Molecular Therapies launches its first thernostic product in prostate cancer treatment

Women in Nuclear: a conversation with Eden Carnegie on Quality Assurance